CCAT1: an oncogenic long noncoding RNA in human cancers Xiaoqiang GuoYuming Hua Review – Cancer Research 16 September 2016 Pages: 555 - 562
Men and women show similar survival rates after breast cancer Paulo Franscisco Mascarenhas BenderLetícia Lima de OliveiraLuiz Claudio Santos Thuler Original Article – Cancer Research 08 December 2016 Pages: 563 - 571
Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines Julia KneisslAnja HartmannBirgit Luber Original Article – Cancer Research Open access 08 December 2016 Pages: 573 - 600
Comprehensive gene and microRNA expression profiling reveals a role for miRNAs in the oncogenic roles of SphK1 in papillary thyroid cancer Weiwei LiangZhiwei XieHongyu Guan Original Article – Cancer Research 10 December 2016 Pages: 601 - 611
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients Richard OfnerCathrin RitterJürgen C. Becker Original Article – Cancer Research 18 December 2016 Pages: 613 - 617
Identification of a prognostic 5-Gene expression signature for gastric cancer Jun-Yi HouYu-Gang WangQian-Ping Li Original Article – Cancer Research 29 December 2016 Pages: 619 - 629
A novel loss-of-function heterozygous BRCA2 c.8946_8947delAG mutation found in a Chinese woman with family history of breast cancer Jing MaJichun YangDuan Ma Original Article – Cancer Research 05 January 2017 Pages: 631 - 637
Depletion of p42.3 gene inhibits proliferation and invasion in melanoma cells Hui LiuMin ZhuWeicheng Xue Original Article – Cancer Research 16 January 2017 Pages: 639 - 648
Study of early stage non-small-cell lung cancer using Orbitrap-based global serum metabolomics Agnieszka KlupczynskaPaweł DerezińskiZenon J. Kokot Original Article – Cancer Research Open access 06 February 2017 Pages: 649 - 659
Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme Jia-Bin WangFeng-Hua LiuZhi-Guo Lin Original Article – Cancer Research 06 February 2017 Pages: 661 - 671
Current developments in cancer care: including the patients’ perspective—3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany O. OrtmannW. Röslerfor the participants of the ERTM Review – Clinical Oncology 17 December 2016 Pages: 673 - 676
Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization Johannes MischingerLutz Philipp GuttenbergTilman Todenhöfer Original Article – Clinical Oncology 02 December 2016 Pages: 677 - 685
Preoperative characteristics of the P.R.O.S.T.A.T.E. scores: a novel predictive tool for the risk of positive surgical margin after radical prostatectomy Ben XuCheng LuoJie Jin Original Article – Clinical Oncology 05 December 2016 Pages: 687 - 692
Fingerprint changes among cancer patients treated with paclitaxel Payam AzadehSimin Dashti-KhavidakiMaryam Farasatinasab Original Article – Clinical Oncology 17 December 2016 Pages: 693 - 701
Prognostic impact of tumour burden measured by quantitative real-time PCR from sentinel lymph nodes of melanoma patients: data from 10-year follow-up Thomas Kurt EigentlerJoachim HindererUlrike Leiter Original Article – Clinical Oncology 19 December 2016 Pages: 703 - 708
Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation Osamu ImatakiKensuke MatsumotoMakiko Uemura Original Article – Clinical Oncology 06 January 2017 Pages: 709 - 715
A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors Constantinos E. AlifierisKyriakos OrfanakosDimitrios T. Trafalis Original Article – Clinical Oncology 11 January 2017 Pages: 717 - 725
Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up Jian-Xian LinQing-Feng ChenChang-Ming Huang Original Article – Clinical Oncology 12 January 2017 Pages: 727 - 734
Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting Thomas M. AtkinsonLauren J. RogakYuelin Li Original Article – Clinical Oncology 16 January 2017 Pages: 735 - 743
